DV
Dividend Vision

IVVD — Invivyd Inc.

Invivyd Inc. (IVVD)

Total return is -96.5% over the past 5 years, 184.2 points behind SPY at 87.7%. Its deepest 1-year drawdown was 81.4%.

Invivyd is a biopharmaceutical company that researches, develops, and commercializes antibody therapies for viral infectious diseases, with a focus on COVID-19 prevention and treatment. The company does not currently distribute dividends to shareholders. Invivyd appeals primarily to investors seeking exposure to clinical-stage biotechnology rather than those focused on income generation.

IVVD key facts

Asset type
Stock
Asset class
Equity
Inception date
08/06/2021
Last close
$0.72
Market cap
$201,894,480
Average volume
2025000.0
Beta
0.671
Payout ratio
0.0
Forward P/E
44.6429
EPS
$-0.27